The current study provided preliminary support for the role of GM-derived PAGln in AF development, revealing that AF patients had elevated relative abundance of porA enzyme, a key PAGln-synthesis-related GM enzyme, in feces and significantly increased PAGln levels in circulation. Here, PPP1R3A is linked to atrial fibrillation.